Cite
HARVARD Citation
Jarisch, A. et al. (2022). SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination. European journal of immunology. 52 (7), pp. 1194-1197. [Online].